Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment
Human epidermal growth factor receptor 2 (HER2) is overexpressed in numerous cancer cell types.Therapeutic antibodies and chimeric antigen receptors (CARs) against HER2 were developed to treat human tumors.The major limitation of anti-HER2 CAR-T lymphocyte therapy is attributable to the low HER2 expression in a wide range of normal tissues.Thus, si